AlphaCentric Advisors’s Globus Medical GMED Stock Holding History

AlphaCentric Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$646K	Sell	7,500 -1,212	-14%	-$109K	0.65%	43
2025 Q4	$761K	Buy	+8,712	New	+$661K	0.76%	35
2024 Q4	$2M	Buy	+24,176	New	+$1.91M	2%	10
2024 Q2	–	Sell	-12,500	Closed	-$671K	–	235
2024 Q1	$671K	Buy	+12,500	New	+$672K	0.4%	77
2023 Q4	–	Sell	-10,000	Closed	-$497K	–	253
2023 Q3	$497K	Buy	+10,000	New	+$559K	0.28%	88
2023 Q1	–	Sell	-10,000	Closed	-$743K	–	214
2022 Q4	$743K	Buy	10,000 +9,000	+900%	+$613K	0.73%	49
2022 Q3	$60K	Buy	+1,000	New	+$60.2K	0.06%	169
2021 Q1	–	Sell	-15,000	Closed	-$978K	–	213
2020 Q4	$978K	Hold	15,000	–	–	0.41%	17
2020 Q3	$743K	Hold	15,000	–	–	0.36%	22
2020 Q2	$716K	Buy	+15,000	New	+$724K	0.4%	21

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCentric Advisors's GMED Position: Q1 2026 in Review

AlphaCentric Advisors reduced its Globus Medical (GMED) stake by 14% in Q1 2026, selling an estimated $109K and leaving 7,500 shares worth $646K. The position accounts for 0.65% of the portfolio, ranked #43.

AlphaCentric Advisors first reported a position in GMED in Q2 2020 and has held it in 10 quarters since. The position peaked at $2M in Q4 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

AlphaCentric Advisors held 7,500 shares of Globus Medical worth $646K as of Q1 2026.
AlphaCentric Advisors sold 1,212 Globus Medical shares in Q1 2026, an estimated $109K.
Globus Medical made up 0.65% of AlphaCentric Advisors's portfolio in Q1 2026, its #43 holding.
AlphaCentric Advisors first reported a position in Globus Medical in Q2 2020 and has held it in 10 quarters since.
AlphaCentric Advisors's Globus Medical position peaked at $2M in Q4 2024.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.